Daniela de Florentiis

627 total citations
22 papers, 463 citations indexed

About

Daniela de Florentiis is a scholar working on Epidemiology, Molecular Biology and Microbiology. According to data from OpenAlex, Daniela de Florentiis has authored 22 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Microbiology. Recurrent topics in Daniela de Florentiis's work include Influenza Virus Research Studies (13 papers), Respiratory viral infections research (10 papers) and Pneumonia and Respiratory Infections (6 papers). Daniela de Florentiis is often cited by papers focused on Influenza Virus Research Studies (13 papers), Respiratory viral infections research (10 papers) and Pneumonia and Respiratory Infections (6 papers). Daniela de Florentiis collaborates with scholars based in Italy, United States and Belarus. Daniela de Florentiis's co-authors include Filippo Ansaldi, Giancarlo Icardi, Paolo Durando, Matteo Bassetti, Mariano Martini, Andrea Orsi, Paola Canepa, Maria Merelli, Claudio Scarparo and Assunta Sartor and has published in prestigious journals such as PLoS ONE, Vaccine and Journal of Medical Virology.

In The Last Decade

Daniela de Florentiis

22 papers receiving 452 citations

Peers

Daniela de Florentiis
Raul Raz Israel
Bernard Vaudaux Switzerland
Hong Foo Australia
Maya Korem Israel
Chi Eun Oh South Korea
Daniela de Florentiis
Citations per year, relative to Daniela de Florentiis Daniela de Florentiis (= 1×) peers Sophie Blumental

Countries citing papers authored by Daniela de Florentiis

Since Specialization
Citations

This map shows the geographic impact of Daniela de Florentiis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela de Florentiis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela de Florentiis more than expected).

Fields of papers citing papers by Daniela de Florentiis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela de Florentiis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela de Florentiis. The network helps show where Daniela de Florentiis may publish in the future.

Co-authorship network of co-authors of Daniela de Florentiis

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela de Florentiis. A scholar is included among the top collaborators of Daniela de Florentiis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela de Florentiis. Daniela de Florentiis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florentiis, Daniela de, Andrea Orsi, Anna Rossi, et al.. (2015). Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance. PubMed. 52(3). 134–6. 4 indexed citations
2.
Bassetti, Matteo, Maria Merelli, Filippo Ansaldi, et al.. (2015). Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study. PLoS ONE. 10(5). e0127534–e0127534. 85 indexed citations
3.
4.
Canepa, Paola, Cristina Eller-Vainicher, Daniela de Florentiis, et al.. (2015). Role of congenital rubella reference laboratory: 21-months-surveillance in Liguria, Italy. PubMed. 50(4). 221–6. 4 indexed citations
5.
Trucchi, Cecilia, Chiara Paganino, Andrea Orsi, Daniela de Florentiis, & Filippo Ansaldi. (2015). Influenza vaccination in the elderly: why are the overall benefits still hotly debated?. PubMed. 56(1). E37–43. 26 indexed citations
6.
Ansaldi, Filippo, Andrea Orsi, Cecilia Trucchi, et al.. (2014). Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults. Human Vaccines & Immunotherapeutics. 11(1). 166–171. 9 indexed citations
7.
Orsi, Andrea, Filippo Ansaldi, Daniela de Florentiis, et al.. (2013). Cross-protection against drifted influenza viruses. Human Vaccines & Immunotherapeutics. 9(3). 582–590. 29 indexed citations
8.
Ansaldi, Filippo, Daniela de Florentiis, Paola Canepa, et al.. (2013). Carriage ofStreptoccoccus pneumoniaein healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children. Human Vaccines & Immunotherapeutics. 9(3). 614–620. 23 indexed citations
9.
Ansaldi, Filippo, et al.. (2013). Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60. Human Vaccines & Immunotherapeutics. 9(3). 591–598. 20 indexed citations
10.
Ansaldi, Filippo, Daniela de Florentiis, Paola Canepa, et al.. (2012). Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. Vaccine. 30(13). 2288–2294. 17 indexed citations
11.
Ansaldi, Filippo, Paola Canepa, Antonella Ceravolo, et al.. (2012). Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine. 30(18). 2908–2913. 21 indexed citations
12.
Ansaldi, Filippo, Daniela de Florentiis, Mariano Martini, et al.. (2012). Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness.. PubMed. 53(2). 94–7. 6 indexed citations
13.
Ansaldi, Filippo, Daniela de Florentiis, Giuseppe Murdaca, et al.. (2012). Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine vs. standard-dose intramuscular vaccine in HIV-1-infected adults. Human Vaccines & Immunotherapeutics. 8(8). 1048–1052. 13 indexed citations
14.
Florentiis, Daniela de, et al.. (2011). Inactivated Influenza Vaccines. Drugs & Aging. 28(2). 93–106. 38 indexed citations
15.
Ansaldi, Filippo, Daniela de Florentiis, Paolo Durando, & Giancarlo Icardi. (2011). Fluzone®Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults. Expert Review of Vaccines. 11(1). 17–25. 29 indexed citations
16.
Bassetti, Matteo, Elena Nicco, Francesca Ginocchio, et al.. (2010). High-dose daptomycin in documented Staphylococcus aureus infections. International Journal of Antimicrobial Agents. 36(5). 459–461. 57 indexed citations
17.
Ansaldi, Filippo, Paola Canepa, Daniela de Florentiis, et al.. (2010). Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine. Clinical and Vaccine Immunology. 18(2). 343–345. 24 indexed citations
18.
Ansaldi, Filippo, Pierlanfranco D’Agaro, Daniela de Florentiis, et al.. (2004). Three-Year (1999–2002) of Epidemiological and Virological Surveillance of Influenza in North-East Italy. European Journal of Epidemiology. 19(9). 885–890. 5 indexed citations
19.
Ansaldi, Filippo, et al.. (2004). An outbreak of hepatitis C virus in a haemodialysis unit: molecular evidence of patient-to-patient transmission.. PubMed. 15(5). 685–91. 3 indexed citations
20.
Ansaldi, Filippo, Pierlanfranco D’Agaro, Daniela de Florentiis, et al.. (2003). Molecular characterization of influenza B viruses circulating in northern Italy during the 2001–2002 epidemic season. Journal of Medical Virology. 70(3). 463–469. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026